当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2010年第17期
编号:11956190
22例辛伐他汀联合胺碘酮在心房颤动中的效果观察
http://www.100md.com 2010年6月15日 《中国医药导报》 2010年第17期
     [摘要] 目的:探讨辛伐他汀联合胺碘酮在心房颤动中的临床效果。方法:选取2008年1月~2009年1月于我院进行治疗的40例心房颤动患者为研究对象,将其随机分为胺碘酮组(对照组)18例和辛伐他汀联合胺碘酮组(观察组)22例,后将两组患者的治疗总有效率、副作用发生率及并发症发生率等进行统计及比较。结果:经比较后发现,观察组的总有效率高于对照组(P<0.05),副作用发生率两组差异不大(P>0.05),而观察组的并发症发生率却明显低于对照组(P<0.05)。结论:在心房颤动的治疗中采用辛伐他汀联合胺碘酮的治疗方案,具有效果好、安全性高及降低并发症发生率的作用,值得推广应用。

    [关键词] 辛伐他汀;胺碘酮;心房颤动

    [中图分类号] R541.7 [文献标识码]B[文章编号]1673-7210(2010)06(b)-158-02

    Effect observation of Simvastatin combined with Amiodarone in 22 patients with atrial fibrillation

    GAO Jing

    (Medicine of Qinghe District Hospital of Tieling City, Tieling 112003, China)

    [Abstract] Objective: To study the clinical effects of Simvastatin combined with Amiodarone in the patients with atrial fibrillation. Methods: 40 patients with atrial fibrillation in our hospital from January 2008 to January 2009 were selected as research subjects,and they were divided into Amiodarone group (control group) 18 cases and Simvastatin combined with Amiodarone group (observation group) 22 cases,then the total effective rate,incidence of side effects and incidence of complications of the two groups were analyzed and compared. Results: The total effective rate of the observation group was higher than that of control group(P<0.05), the incidence of side effects of the two groups had no difference(P>0.05), but the incidence of complications of the observation group was lower than that of control group(P<0.05). Conclusion:The effect of simvastatin combined with amiodarone in the patients with atrial fibrillation is better, it has high safety and low incidence of complications, and it is worthy of popularization and application. ......

您现在查看是摘要页,全文长 5268 字符